SIX Structured Products | Bid | Ask | Notation | |
---|---|---|---|---|
Please note that data is only available after start of trading. |
Closing prev. day | 3.320 | ||||
Diff. absolute / % | -0.49 | -14.76% |
Last Price | - | Volume | - | |
Time | - | Date | - |
Details | Underlying | Payment profile | Risk Indicator | Information & Tools | Similar Products |
Name | Novartis AG |
ISIN | CH1292040495 |
Valor | 129204049 |
Symbol | TNOVNU |
Type | Constant Leverage Certificate |
Type | Bull |
Ratio | 3.39 |
Factor | 8 |
SVSP Code | 2300 |
COSI Product | No |
Exercise type | Bermuda |
Currency | Swiss Franc |
First Trading Date | 05/10/2023 |
Settlement Type | Cash payout |
IRS 871m | Not applicable |
Currency safeguarded | No |
Pricing | Dirty |
Issuer | UBS |
Average Spread | 2.41% |
Last Best Bid Price | 3.24 CHF |
Last Best Ask Price | 3.32 CHF |
Last Best Bid Volume | 20,000 |
Last Best Ask Volume | 20,000 |
Average Buy Volume | 20,000 |
Average Sell Volume | 20,000 |
Average Buy Value | 65,682 CHF |
Average Sell Value | 67,282 CHF |
Spreads Availability Ratio | 98.93% |
Quote Availability | 98.93% |